Study to Evaluate Safety of Transitioning From Alendronate to A Single Dose of Denosumab in Postmenopausal Women with Low Bone Mass

Sponsor ID

20050241

Clinicaltrials.gov ID

EUCTIS ID

N/A

EudraCT ID

N/A

Study Details

Phase

Phase 1

Product

denosumab

Type

Interventional

Masking

N/A

Enrollment

N/A

Additional Study Details

Primary Outcome Measures

Not Available

Secondary Outcome Measures

Not Available

Study Synopsis

Available Language(s): English

No locations found.